Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal versus intravenous dexamethasone for prevention of postoperative nausea and vomiting after cesarean delivery with intrathecal morphine
PACTR202507584655206Phase 3Completed
- Sponsor
- Aswan University Hospital
- Start
- Aug 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dexamethasone in postoperative nausea and vomiting (PONV) (2 arms), sponsored by Aswan University Hospital. Primary endpoint: Maternal satisfaction at 24 hours. Started Aug 2021; status: completed.
02
Drugs
dexamethasone
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on PACTR202507584655206.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202507584655206.